1 Healthcare Stock to Research Further and 2 Facing Headwinds [Yahoo! Finance]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Yahoo! Finance
Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.4% over the past six months, topping the S&P 500 by 7.8 percentage points. Nevertheless, investors should tread carefully as the sector is heavily regulated, and businesses can be negatively impacted if the rules change. With that said, here is one healthcare stock boasting a durable advantage and two that may face trouble. Market Cap: $5.97 billion With a nearly 170-year history dedicated to vision care and eye health innovation, Bausch + Lomb (NYSE:BLCO) develops and manufactures a comprehensive range of eye health products including contact lenses, pharmaceuticals, surgical devices, and consumer eye care solutions. Why Does BLCO Worry Us? Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 20.4% annually Free cash flow margin dropped by 26.8 percentage points over the last five years, implying the
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- SCOTT WOODWARD NAMED 2025 DISTINGUISHED ALUMNUS [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb (NYSE:BLCO) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
- Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18Business Wire
- Bausch + Lomb CEO Brent Saunders sits down with Jim Cramer [CNBC]CNBC
- Trump says DEI, civil rights policies hurt White people. Do they? [USA TODAY]USA TODAY
BLCO
Earnings
- 10/29/25 - Beat
BLCO
Sec Filings
- 1/9/26 - Form 3
- 1/9/26 - Form 3
- 1/2/26 - Form 8-K
- BLCO's page on the SEC website